Downloads


White Paper: Ten Most Common Reasons For FDA 483 Observations And Warning Letter Citations

MasterControl
File Size: 341.1 KB   Estimated Download Time: < 1 min
Description

White Paper: Ten Most Common Reasons For FDA 483 Observations And Warning Letter Citations At a recent Intermountain Biomedical Association workshop held in Lehi, Utah, Barbara Cassens, Director of the FDA's San Francisco District Office, identified ten specific FDA regulated areas in which medical device companies most commonly receive FDA-483 Observations and Warning Letter citations. This white paper also introduces the MasterControl Solution and how it can help avoid FDA 483 Observations and Warning Letters. Submitted by MasterControl

Read more...

Most Popular

Need Information?

Please wait... busy